AN OPEN-LABEL, LONG-TERM EXTENSION STUDY TO EVALUATE SAFETY AND EFFICACY OF ATUMELNANT IN PARTICIPANTS WITH CONGENITAL ADRENAL HYPERPLASIA

Registry ID

CRN04894-09

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

CRINETICS PHARMACEUTICALS, INC.

Last update

2026-05-21

Conditions

• CONGENITAL ADRENAL HYPERPLASIA

Related clinical trials

• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CRINECERFONT (NBI-74788) IN PEDIATRIC SUBJECTS WITH CLASSIC CONGENITAL ADRENAL HYPERPLASIA, FOLLOWED BY OPEN-LABEL TREATMENT

View on source registry